Arkolith/Insider Trading/CERO/Form 4

Atwood Brian G

DirectorCERO THERAPEUTICS HOLDINGS, INC. (CERO) · full profile →Form 4 · filed Feb 7, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
0 non-derivative · 4 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 7, 2025Grant(A)306K—$0306K
Feb 7, 2025Grant(A)204K$1.96$400K204K
Feb 7, 2025Grant(A)306K$1.96$600K306K
Feb 7, 2025Grant(A)204K—$0204K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-25-011409) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML